Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Antenatal Exposure to Selective Serotonin Reuptake Inhibitors (SSRIs) Associated With Prolongation of the QT Interval in Term Neonates (Greater Than 37 Complete Weeks Gestation)?

NCT02492347 is registered in ClinicalTrials.gov with University of Southampton as lead sponsor.

NCT NCT02492347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02492347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Antenatal Exposure to Selective Serotonin Reuptake Inhibitors (SSRIs) Associated With Prolongation of the QT Interval in Term Neonates (Greater Than 37 Complete Weeks Gestation)?
Lead sponsor
University of Southampton
Phase
Not applicable
Overall status
Completed
Start date
February 18, 2016
Completion date
August 18, 2017
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse effect of selective serotonin reuptake inhibitors, qt interval, variation in